Sign In to Follow Application
View All Documents & Correspondence

Crystal Form Vii Of Melanocortin Receptor Agonist Compound And Method For Preparing Same

Abstract: The present invention relates to a crystal form VII of a compound represented by chemical formula 1, a method for preparing same, and a pharmaceutical composition comprising same. The crystal form VII of the compound represented by chemical formula 1, according to the present invention, can be characterized by an XRD pattern, a DSC profile, and/or a TGA profile.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
30 October 2023
Publication Number
37/2024
Publication Type
INA
Invention Field
CHEMICAL
Status
Email
Parent Application

Applicants

LG CHEM, LTD.
128, Yeoui-daero Yeongdeungpo-gu Seoul 07336

Inventors

1. LEE, Ho Yeon
LG Chem Research Park, 188, Munji-ro Yuseong-gu Daejeon 34122
2. HAM, Jin Ok
LG Chem Research Park, 188, Munji-ro Yuseong-gu Daejeon 34122
3. LEE, Sang Dae
LG Chem Research Park, 188, Munji-ro Yuseong-gu Daejeon 34122
4. KIM, Ji Yoon
LG Chem Research Park, 188, Munji-ro Yuseong-gu Daejeon 34122
5. PARK, Jong Won
LG Chem Research Park, 188, Munji-ro Yuseong-gu Daejeon 34122
6. KIM, Sung Won
LG Chem Research Park, 188, Munji-ro Yuseong-gu Daejeon 34122
7. CHUN, Seul Ah
LG Chem Research Park, 188, Munji-ro Yuseong-gu Daejeon 34122

Specification

Documents

Application Documents

# Name Date
1 202317073871-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [30-10-2023(online)].pdf 2023-10-30
2 202317073871-STATEMENT OF UNDERTAKING (FORM 3) [30-10-2023(online)].pdf 2023-10-30
3 202317073871-PROOF OF RIGHT [30-10-2023(online)].pdf 2023-10-30
4 202317073871-POWER OF AUTHORITY [30-10-2023(online)].pdf 2023-10-30
5 202317073871-FORM 1 [30-10-2023(online)].pdf 2023-10-30
6 202317073871-DRAWINGS [30-10-2023(online)].pdf 2023-10-30
7 202317073871-DECLARATION OF INVENTORSHIP (FORM 5) [30-10-2023(online)].pdf 2023-10-30
8 202317073871-COMPLETE SPECIFICATION [30-10-2023(online)].pdf 2023-10-30
9 202317073871-MARKED COPIES OF AMENDEMENTS [06-11-2023(online)].pdf 2023-11-06
10 202317073871-FORM 13 [06-11-2023(online)].pdf 2023-11-06
11 202317073871-AMMENDED DOCUMENTS [06-11-2023(online)].pdf 2023-11-06
12 202317073871-FORM 18 [07-11-2023(online)].pdf 2023-11-07
13 202317073871-FORM 3 [30-05-2024(online)].pdf 2024-05-30
14 202317073871-FORM 3 [28-11-2024(online)].pdf 2024-11-28